Figure 8.

Proposed pathway for Eze and its downstream targets. Eze increases levels of phosphorylated AMPK and activates Nrf2, which translocates into the nucleus to increase the transcription of HO-1—a protein that inhibits ROS and inflammation.

Proposed pathway for Eze and its downstream targets. Eze increases levels of phosphorylated AMPK and activates Nrf2, which translocates into the nucleus to increase the transcription of HO-1—a protein that inhibits ROS and inflammation.